Skip to main content
Molecular Therapy logoLink to Molecular Therapy
. 2022 Mar 25;30(4):1787. doi: 10.1016/j.ymthe.2022.03.013

lncRNA Linc00173 modulates glucose metabolism and multidrug chemoresistance in SCLC: Potential molecular panel for targeted therapy

Shuyu Wang, Fanrui Zeng, Shumei Liang, Qiuping Wang, Yang Wen, Qiongyao Wang, Jiexia Zhang, Man Li, Shun Fang, Ting Wei, Minglun Li, Farkhad Manapov, Jian Zhang, Linlang Guo
PMCID: PMC9077365  PMID: 35334209

Main Text

(Molecular Therapy 30, https://doi.org/10.1016/j.ymthe.2021.11.003; April 6, 2022)

Image analyses performed on western blot files used in in Figures 1I, 1J, 3F, S5B, and S6B of this article revealed evidence of image duplication and manipulation. Given these concerns, the editors and publisher are conducting an investigation to determine if a retraction is warranted.


Articles from Molecular Therapy are provided here courtesy of The American Society of Gene & Cell Therapy

RESOURCES